Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,004 | 6,048 | 7,150 | 8,266 | 9,104 |
| Receivables | 27 | 77 | 25 | 44 | 122 |
| TOTAL | $5,052 | $6,230 | $7,307 | $8,427 | $9,354 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 0 | 2 |
| Other Non-Current Assets | 49 | 63 | 76 | 89 | 109 |
| TOTAL | $49 | $63 | $76 | $89 | $110 |
| Total Assets | $5,101 | $6,293 | $7,382 | $8,516 | $9,463 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 154 | 479 | 689 | 338 | 1,100 |
| TOTAL | $208 | $536 | $744 | $389 | $1,153 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $10 | $26 | $40 | $56 |
| Total Liabilities | $208 | $547 | $769 | $430 | $1,209 |
| Shareholders' Equity | |||||
| Common Shares | 25,148 | 25,226 | 25,070 | 24,834 | 25,239 |
| Retained earnings | -23,392 | -22,328 | -21,112 | -19,546 | -18,927 |
| Other shareholders' equity | 3,137 | 2,849 | 2,656 | 2,798 | 1,941 |
| TOTAL | $4,893 | $5,746 | $6,613 | $8,086 | $8,254 |
| Total Liabilities And Equity | $5,101 | $6,293 | $7,382 | $8,516 | $9,463 |